Olodaterol Suppliers & Bulk Manufacturers
Available Forms: Inhalation solution
Available Strengths: 2.5 mcg
Reference Brands: Striverdi Respimat (USA)
Category:
Respiratory Disorder
Olodaterol is available in Inhalation solution
and strengths such as 2.5 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Olodaterol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Olodaterol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Olodaterol is an ultra-long-acting beta-2 adrenergic receptor agonist (ultra-LABA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the airway muscles, improving airflow, and helping patients breathe more easily. Olodaterol is designed for once-daily use, providing sustained bronchodilation over 24 hours, which helps reduce symptoms such as shortness of breath and wheezing. While it may help decrease the frequency of COPD exacerbations, it does not slow the progression of the disease or extend life expectancy. Olodaterol is typically administered via inhalation and is intended as a long-term maintenance therapy rather than for immediate relief of acute symptoms. The medication is marketed under the brand name Striverdi Respimat and is manufactured by Boehringer Ingelheim. It is commonly used in patients requiring regular bronchodilator therapy to manage airflow obstruction and improve daily respiratory function.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing